Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
NCT ID: NCT04565080
Last Updated: 2021-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2020-10-29
2021-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary objectives:
To evaluate the change in neurological symptoms domain of the survey between pre and post-COVID 19 in FMD and PD patients.
Secondary objectives:
* To evaluate the change in total score of the survey between pre and post COVID 19 in FMD and PD patients
* To evaluate the change in other symptom domains of the survey between pre and post COVID 19 in FMD and PD patients. Domains include: Mood/Energy, sleep, symptoms of abnormal movements related or unrelated to primary disease, physical health and exercise related change
Exploratory objectives:
* To evaluate whether there is a modifying effect of disease group in the changes in total score or symptom domains
* To evaluate whether there is a relationship between disease severity and changes in total score or symptom domains
* To evaluate whether there is a correlation between changes across symptom domains
* To evaluate whether there is a correlation in raw score across symptom domains within each period
Research Methods:
Data will be solely collected through the use of online instruments via CiSTAR as a designed questionnaire.
Questionnaire items
A questionnaire aimed at determining the effects of the COVID 19 pandemic and subsequent isolation on functional state of patients with FMD and PD.
The questionnaire items include:
Items investigating Mood/Energy before and after COVID 19 out break
Items investigating Sleep habits before and after COVID 19 out break
Items investigating Neurological symptoms before and after COVID 19 out break
Items investigating daily functioning before and after COVID 19 out break
Items investigating Exercise habits before and after COVID 19 out break
No questionnaire items will be actionable , which are items that would identify an imminent risk for participant safety requiring urgent and immediate medical or psychiatric
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objectives:
To evaluate the change in neurological symptoms domain of the survey between pre and post-COVID 19 in FMD and PD patients.
Secondary objectives:
* To evaluate the change in total score of the survey between pre and post COVID 19 in FMD and PD patients
* To evaluate the change in other symptom domains of the survey between pre and post COVID 19 in FMD and PD patients. Domains include: Mood/Energy, sleep, symptoms of abnormal movements related or unrelated to primary disease, physical health and exercise related change
Exploratory objectives:
* To evaluate whether there is a modifying effect of disease group in the changes in total score or symptom domains
* To evaluate whether there is a relationship between disease severity and changes in total score or symptom domains
* To evaluate whether there is a correlation between changes across symptom domains
* To evaluate whether there is a correlation in raw score across symptom domains within each period
Research Methods:
Data will be solely collected through the use of online instruments via CiSTAR as a designed questionnaire.
Questionnaire items
A questionnaire aimed at determining the effects of the COVID 19 pandemic and subsequent isolation on functional state of patients with FMD and PD.
The questionnaire items include:
Items investigating Mood/Energy before and after COVID 19 out break
Items investigating Sleep habits before and after COVID 19 out break
Items investigating Neurological symptoms before and after COVID 19 out break
Items investigating daily functioning before and after COVID 19 out break
Items investigating Exercise habits before and after COVID 19 out break
No questionnaire items will be actionable , which are items that would identify an imminent risk for participant safety requiring urgent and immediate medical or psychiatric
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FMD Patients
adult FMD patients who participated in protocol 07-N-0190
No interventions assigned to this group
PD Patients
adult PD patients who participated in protocol 01-N-0206
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. (for PD subjects only) Clinical diagnosis of Parkinson s Disease as confirmed by a movement disorders specialist in subjects previously enrolled in protocol 01-N-0206.
3. Able to give informed consent
4. Male or female, age 18 and above
5. Have access to the internet in order to fill out the survey
6. Have enough fluency in English to be able to read the consent form and take the survey in English
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Hallett, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000159-N
Identifier Type: -
Identifier Source: secondary_id
10000159
Identifier Type: -
Identifier Source: org_study_id